Patents by Inventor Cyrille Kuhn

Cyrille Kuhn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190002436
    Abstract: Compounds of Formula (I): (Formula I), wherein Z1 is NR1A, CHR1A, CR1BR1B; one of Z2 and Z3 is CH or CR1A?, the other is N, CH or CR1A?; n is 0, 1 or 2; q is 0, 1 or 2; R1A, R1A?, R1B, R2, and R3 are as defined herein, their use as inhibitors of RSV and related aspects.
    Type: Application
    Filed: July 28, 2016
    Publication date: January 3, 2019
    Inventors: Susana AYESA, Karolina ERSMARK, Gennadiy KALAYANOV, Marie LEIJONMARCK, Lourdes Salvador ODEN, Hans WESTERLIND, Horst WAHLING, Megan BERTRAND, Christian BROCHU, Elise GHIRO, Cyrille KUHN, Claudio STURINO, Johan BYLUND, Fernando SEHGELMEBLE, Stina LUNDGREN
  • Patent number: 9708332
    Abstract: Compounds of Formula (I), wherein R1, R2, R3, R4 and n are defined herein, are useful as inhibitors of RSV.
    Type: Grant
    Filed: October 29, 2013
    Date of Patent: July 18, 2017
    Assignee: MEDIVIR AB
    Inventors: Claudio Sturino, Teddy Halmos, Anne Decor, Martin Duplessis, Patrick Deroy, Araz Jakalian, Louis Morency, Cyrille Kuhn, Chantal Grand-Maitre, Martin Tremblay, Christian Brochu
  • Patent number: 9505775
    Abstract: Compounds of Formula (I) wherein R1, R2, R3A, R3B, Y, Z1 and Z2 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
    Type: Grant
    Filed: October 31, 2013
    Date of Patent: November 29, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Carl Thibeault, Jean Rancourt, Pierre L. Beaulieu, Anne Décor, Chantal Grand-Maitre, Cyrille Kuhn, Elisia Villemure, Oliver Hucke, Simon Surprenant, Melissa Leblanc, Jean-Eric Lacoste, Benoit Moreau, Eric Jolicoeur
  • Publication number: 20160272646
    Abstract: Compounds of Formula (I), wherein R1, R2, R3, R4 and n are defined herein, are useful as inhibitors of RSV.
    Type: Application
    Filed: October 29, 2013
    Publication date: September 22, 2016
    Inventors: Claudio STURINO, Teddy HALMOS, Anne DECOR, Martin DUPLESSIS, Patrick DEROY, Araz JAKALIAN, Louis MORENCY, Cyrille KUHN, Chantal GRAND-MAITRE, Martin TREMBLAY, Christian BROCHU
  • Patent number: 9340548
    Abstract: The invention relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 are defined herein, and their use for the treatment of hepatitis C viral infection.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: May 17, 2016
    Assignee: Boehringer Ingehleim International GmbH
    Inventors: Christian Brochu, Chantal Grand-Maitre, Marc-Andre Joly, Cyrille Kuhn, Megan Bertrand-Laperle, Marc Pesant
  • Patent number: 9340539
    Abstract: A compound of formula (I) useful for the treatment or prevention of hepatitis C viral infection, (Formula (I)) wherein: X1 and X2 are each independently CRB or N; RB is H, (C1-6)alkyl, (C1-6)haloalkyl, halo.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: May 17, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Christian Brochu, Chantal Grand-Maitre, Lee Fader, Cyrille Kuhn, Megan Bertrand-Laperle, Marc Pesant
  • Patent number: 9284310
    Abstract: Compounds of Formula (I) wherein n, R1, R1A, R2, R3, Y and Z are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
    Type: Grant
    Filed: October 31, 2013
    Date of Patent: March 15, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Lee Fader, Francois Bilodeau, Mathieu Parisien, Maude Poirier, Cyrille Kuhn, Carl Thibeault, Thao Trinh
  • Publication number: 20150315180
    Abstract: Compounds of Formula (I) wherein n, R1, R1A, R2, R3, Y and Z are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
    Type: Application
    Filed: October 31, 2013
    Publication date: November 5, 2015
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Lee FADER, Francois BILODEAU, Mathieu PARISIEN, Maude POIRIER, Cyrille KUHN, Carl THIBEAULT, Thao TRINH
  • Publication number: 20150291592
    Abstract: Compounds of Formula (I) wherein n, X1, X2, R1, R2, Y1, Y2 and RA are defined herein, are useful for the treatment of hepatitis C viral infection.
    Type: Application
    Filed: August 22, 2012
    Publication date: October 15, 2015
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Christian Brochu, Chantal Grand-Maitre, Marc-Andre Joly, Cyrille Kuhn, Megan Bertrand-Laperle, Marc Pesant
  • Publication number: 20140343077
    Abstract: A compound of formula (I) useful for the treatment or prevention of hepatitis C viral infection, (Formula (I)) wherein: X1 and X2 are each independently CRB or N; RB is H, (C1-6)alkyl, (C1-6)haloalkyl, halo.
    Type: Application
    Filed: August 22, 2012
    Publication date: November 20, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Christian Brochu, Chantal Grand-Maitre, Lee Fader, Cyrille Kuhn, Megan Bertrand-Laperle, Marc Pesant
  • Publication number: 20070197587
    Abstract: The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the description, their use as medicament, pharmaceutical compositions containing them and processes for their preparation.
    Type: Application
    Filed: April 16, 2007
    Publication date: August 23, 2007
    Inventors: Mohamed Ali Awad, Marc Bazin, Frederic Feru, Steven Goldstein, Cyrille Kuhn
  • Publication number: 20040214845
    Abstract: The invention relates to a pharmaceutical composition comprising a compound of the formula (I): 1
    Type: Application
    Filed: May 19, 2004
    Publication date: October 28, 2004
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Marc Bazin, Geraldine C. Harriman, Cyrille Kuhn, Jay R. Luly
  • Publication number: 20030105119
    Abstract: The invention relates to a pharmaceutical composition comprising a compound of the formula (I): 1
    Type: Application
    Filed: February 22, 2002
    Publication date: June 5, 2003
    Inventors: Marc Bazin, Geraldine C. Harriman, Cyrille Kuhn, Jay R. Luly